[Federal Register Volume 62, Number 32 (Tuesday, February 18, 1997)]
[Notices]
[Pages 7237-7240]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 97-3821]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
Advisory Committees; Tentative Schedule of Meetings for 1997
AGENCY: Food and Drug Administration, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Food and Drug Administration (FDA) is announcing a
tentative schedule of forthcoming meetings of its public advisory
committees for 1997. At the request of the Commissioner of Food and
Drugs (the Commissioner), the Institute of Medicine (the IOM) conducted
a study of the use of FDA's advisory committees. The IOM recommended
that the agency publish an annual tentative schedule of its meetings in
the Federal Register. In response to that recommendation, FDA is
publishing its
[[Page 7238]]
annual tentative schedule of meetings for 1997.
FOR FURTHER INFORMATION CONTACT: Donna M. Combs, Committee Management
Office (HFA-306), Food and Drug Administration, 5600 Fishers Lane,
Rockville, MD 20857, 301-827-4820.
SUPPLEMENTARY INFORMATION: The IOM, at the request of the Commissioner,
undertook a study of the use of FDA's advisory committees. In its final
report, the IOM recommended that FDA adopt a policy of publishing an
advance yearly schedule of its upcoming public advisory committee
meetings in the Federal Register. FDA has implemented this
recommendation. A tentative schedule of forthcoming meetings will be
published annually in the Federal Register. The annual publication of
tentatively scheduled advisory committee meetings will provide both
advisory committee members and the public with the opportunity, in
advance, to schedule attendance at FDA's upcoming advisory committee
meetings. The schedule is tentative and amendments to this notice will
not be published in the Federal Register. FDA will, however, publish a
Federal Register notice at least 15 days in advance of each upcoming
advisory committee meeting, announcing the meeting (21 CFR 14.20).
The following list announces FDA's tentatively scheduled advisory
committee meetings for 1997:
------------------------------------------------------------------------
Hotline
Committee name Dates of meetings code
------------------------------------------------------------------------
OFFICE OF THE COMMISSIONER
Science Board to the Food and Drug March 13........... 12603
Administration
May 14
November 5
CENTER FOR BIOLOGICS EVALUATION AND
RESEARCH
Allergenic Products Advisory April 17-18........ 12388
Committee
September 29-30
Biological Response Modifiers January 30......... 12388
Advisory Committee
May 6-7
July 24-25
October 16-17
Blood Products Advisory Committee March 13-14........ 12388
June 19-20
September 18-19
December 11-12
Transmissible Spongiform To be announced 12388
Encephalopathies Advisory (presently,
Committee committee is
unstaffed).
Vaccines and Related Biological January 30......... 12388
Products Advisory Committee
March 14
April 10-11
July 10-11
October 27-28
CENTER FOR DRUG EVALUATION AND
RESEARCH
Advisory Committee for May 7-8............ 12539
Pharmaceutical Science
August 20-21
Advisory Committee for June 5-6........... 12537
Reproductive Health Drugs
Anesthetic and Life Support Drugs March 27-28........ 12529
Advisory Committee
May 22-23
September 17-18
Anti-Infective Drugs Advisory January 22 (joint 12530
Committee meeting with
Nonprescription
Drugs Advisory
Committee)
March 5-7
July 24-25
November 20-21
Antiviral Drugs Advisory Committee February 21........ 12531
April 24-25
September 11-12
Arthritis Advisory Committee February 4-5....... 12532
March 18-19
May 6-7
July 22-23
November 4-5
Cardiovascular and Renal Drugs January 23 (joint 12533
Advisory Committee meeting with
Nonprescription
Drugs Advisory
Committee)
February 27-28
June 26-27
October 23-24
Dermatologic and Ophthalmic Drugs April 17-18........ 12534
Advisory Committee
July 17-18
September 15-16
November 13-14
Drug Abuse Advisory Committee February 10-11..... 12535
June 9-10
November 20-21
Endocrinologic and Metabolic Drugs February 20-21..... 12536
Advisory Committee
[[Page 7239]]
March 25-26
April 14-15
May 13-14
July 10-11
August 21-22
September 22-23
November 20-21
Gastrointestinal Drugs Advisory September 18-19.... 12538
Committee
December 2
Medical Imaging Drugs Advisory March 6-7.......... 12540
Committee
Nonprescription Drugs Advisory January 22 (joint 12541
Committee meeting with Anti-
Infective Drugs
Advisory
Committee)
January 23 (joint
meeting with
Cardiovascular and
Renal Drugs
Advisory
Committee)
March 17-19
May 13-14 (with
representation
from
Endocrinologic and
Metabolic Drugs
Advisory
Committee)
Oncologic Drugs Advisory Committee March 7............ 12542
May 1-2
June 23-24
Peripheral and Central Nervous June 26-27......... 12543
System Drugs Advisory Committee
Psychopharmacologic Drugs Advisory July 14-16......... 12544
Committee
August 4-5
November 5-7
Pulmonary-Allergy Drugs Advisory April 10-11........ 12545
Committee
CENTER FOR FOOD SAFETY AND APPLIED
NUTRITION
Food Advisory Committee March 20-21........ 10564
May 21-23
July 30-31 and
August 1
September 24-26
November 19-21
CENTER FOR DEVICES AND RADIOLOGICAL
HEALTH
Device Good Manufacturing Practice No meetings planned 12398
Advisory Committee
Medical Devices Advisory Committee ...................
Anesthesiology and Respiratory June 6............. 12624
Therapy Devices Panel
September 5
November 21
Circulatory System Devices Panel June 16............ 12625
November 17
Clinical Chemistry and Clinical March 20-21....... 12514
Toxicology Devices Panel
May 8
July 24-25
September 25-26
Dental Products Panel February 12........ 12518
May 21-23
July 14-16
November 3-5
Ear, Nose, and Throat Devices May 20-21.......... 12522
Panel
October 22-23
December 11-12
Gastroenterology-Urology Devices January 16......... 12523
Panel
May 1-2
August 7-8
November 6-7
General and Plastic Surgery May 5-6............ 12519
Devices Panel
August 4-5
November 3-4
General Hospital and Personal June 2-3........... 12520
Use Devices Panel
September 15-16
November 13-14
Hematology and Pathology Devices June 26-27......... 12515
Panel
September 4-5
November 20-21
Immunology Devices Panel June 13............ 12516
September 19
December 5
Microbiology Devices Panel June 19-20......... 12517
September 11-12
Neurological Devices Panel March 14........... 12513
June 27
Obstetrics-Gynecology Devices April 14-15........ 12524
Panel
[[Page 7240]]
July 14-15
October 6-7
Ophthalmic Devices Panel January 13-14...... 12396
March 27-28
July 10-11
October 20-21
Orthopedic and Rehabilitation March 6-7.......... 12521
Devices Panel
June 9-10
October 15-16
Radiological Devices Panel February 24........ 12526
May 12
August 18
November 17
National Mammography Quality January 13-15...... 12397
Assurance Advisory Committee
August 18-20
November 3-5
Technical Electronic Product April 8-9.......... 12399
Radiation Safety Standards
Committee
CENTER FOR VETERINARY MEDICINE
Veterinary Medicine Advisory May 13-14.......... 12546
Committee
NATIONAL CENTER FOR TOXICOLOGICAL
RESEARCH
Advisory Committee on Special September 15-16.... 12560
Studies Relating to the Possible
Long-Term Health Effects of
Phenoxy Herbicides and
Contaminants (Ranch Hand Advisory
Committee)
Science Advisory Board to the June 4-5........... 12559
National Center for Toxicological
Research
------------------------------------------------------------------------
FDA has established an Advisory Committee Information Hotline (the
hotline) using a voice-mail telephone system. The hotline provides the
public with access to the most current information on FDA advisory
committee meetings. The advisory committee hotline, which will
disseminate current information and information updates, can be
accessed by dialing 1-800-741-8138 or 301-443-0572. Each advisory
committee is assigned a 5-digit number. This 5-digit number will appear
in each individual notice of meeting. The hotline will enable the
public to obtain information about a particular advisory committee by
using the committee's 5-digit number. Information in the hotline is
preliminary and may change before a meeting is actually held. The
hotline will be updated when such changes are made.
Dated: February 7, 1997.
Michael A. Friedman,
Deputy Commissioner for Operations.
[FR Doc. 97-3821 Filed 2-14-97; 8:45 am]
BILLING CODE 4160-01-F